Vanguard Group Inc Rx Sight, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,524,510 shares of RXST stock, worth $89.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,524,510

Previous 1,484,010 2.73%

Holding current value

$89.1 Million

Previous $59.8 Million 31.42%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$35.51 - $57.92 $1.44 Million - $2.35 Million	40,500 Added 2.73%	1,524,510 $78.6 Million
Q4 2023 Feb 14, 2024	BUY	$20.91 - $40.9 $1.05 Million - $2.05 Million	50,057 Added 3.49%	1,484,010 $59.8 Million
Q3 2023 Nov 14, 2023	BUY	$27.05 - $33.37 $6.9 Million - $8.51 Million	255,150 Added 21.64%	1,433,953 $40 Million
Q2 2023 Aug 14, 2023	BUY	$16.37 - $28.9 $2.61 Million - $4.6 Million	159,310 Added 15.63%	1,178,803 $33.9 Million
Q1 2023 May 15, 2023	BUY	$12.58 - $16.68 $2.81 Million - $3.72 Million	223,228 Added 28.03%	1,019,493 $17 Million

Q4 2022 Feb 10, 2023	SELL	$9.93 - $14.2 $64,386 - $92,072	-6,484 Reduced 0.81%	796,265 $10.1 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $1.46 Million - $2.07 Million	130,694 Added 19.45%	802,749 $9.63 Million
Q2 2022 Aug 12, 2022	BUY	$10.61 - $16.66 $352,697 - $553,811	33,242 Added 5.2%	672,055 $9.46 Million
Q1 2022 May 13, 2022	BUY	$8.97 - $14.03 $2.7 Million - $4.22 Million	301,055 Added 89.13%	638,813 $7.91 Million
Q4 2021 Feb 14, 2022	SELL	$9.52 - $13.81 $664,448 - $963,868	-69,795 Reduced 17.13%	337,758 $3.8 Million
Q3 2021 Nov 12, 2021	BUY	$11.85 - $17.32 $4.83 Million - $7.06 Million	407,553 New	407,553 $5.16 Million

Others Institutions Holding RXST

# of Institutions

199

Shares Held

25.6M

Call Options Held

67K

Put Options Held

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.62B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Rx Sight, Inc. Transaction History